Shanghai Key Laboratory of Maternal Fetal Medicine, Clinical and Translational Research Center of Shanghai First Maternity and Infant Hospital, School of Life Sciences and Technology, Tongji University, Shanghai, 200092, China.
Key Laboratory of Spine and Spinal Cord Injury Repair and Regeneration of Ministry of Education, Department of Orthopedics, Tongji Hospital, School of Life Science and Technology, Tongji University, Tongji, 200092, China.
Stem Cell Res Ther. 2024 Mar 5;15(1):64. doi: 10.1186/s13287-024-03660-0.
Premature ovarian failure (POF) has a profound impact on female reproductive and psychological health. In recent years, the transplantation of umbilical cord-derived mesenchymal stem cells (UC-MSCs) has demonstrated unprecedented potential in the treatment of POF. However, the heterogeneity of human UC-MSCs remains a challenge for their large-scale clinical application. Therefore, it is imperative to identify specific subpopulations within UC-MSCs that possess the capability to improve ovarian function, with the aim of reducing the uncertainty arising from the heterogeneity while achieving more effective treatment of POF.
10 × Genomics was performed to investigate the heterogeneity of human UC-MSCs. We used LRP1 as a marker and distinguished the potential therapeutic subpopulation by flow cytometry, and determined its secretory functions. Unsorted UC-MSCs, LRP1 and LRP1 subpopulation was transplanted under the ovarian capsules of aged mice and CTX-induced POF mice, and therapeutic effects was evaluated by assessing hormone levels, estrous cycles, follicle counts, and embryo numbers. RNA sequencing on mouse oocytes and granulosa cells after transplantation was performed to explore the mechanism of LRP1 subpopulation on mouse oocytes and granulosa cells.
We identified three distinct functional subtypes, including mesenchymal stem cells, multilymphoid progenitor cells and trophoblasts. Additionally, we identified the LRP1 subpopulation, which improved ovarian function in aged and POF mice. We elucidated the unique secretory functions of the LRP1 subpopulation, capable of secreting various chemokines, cytokines, and growth factors. Furthermore, LRP1 plays a crucial role in regulating the ovarian microenvironment, including tissue repair and extracellular matrix remodeling. Consistent with its functions, the transcriptomes of oocytes and granulosa cells after transplantation revealed that the LRP1 subpopulation improves ovarian function by modulating the extracellular matrix of oocytes, NAD metabolism, and mitochondrial function in granulosa cells.
Through exploration of the heterogeneity of UC-MSCs, we identified the LRP1 subpopulation capable of improving ovarian function in aged and POF mice by secreting various factors and remodeling the extracellular matrix. This study provides new insights into the targeted exploration of human UC-MSCs in the precise treatment of POF.
卵巢早衰(POF)对女性生殖和心理健康有深远的影响。近年来,脐带间充质干细胞(UC-MSCs)的移植在 POF 的治疗中显示出前所未有的潜力。然而,UC-MSCs 的异质性仍然是其大规模临床应用的一个挑战。因此,迫切需要鉴定 UC-MSCs 中的特定亚群,这些亚群具有改善卵巢功能的能力,以减少异质性带来的不确定性,同时实现对 POF 的更有效治疗。
使用 10× Genomics 技术研究人类 UC-MSCs 的异质性。我们使用 LRP1 作为标记物,通过流式细胞术区分潜在的治疗亚群,并确定其分泌功能。未分选的 UC-MSCs、LRP1 和 LRP1 亚群被移植到老年小鼠和 CTX 诱导的 POF 小鼠的卵巢囊中,并通过评估激素水平、发情周期、卵泡计数和胚胎数量来评估治疗效果。移植后对小鼠卵母细胞和颗粒细胞进行 RNA 测序,以探讨 LRP1 亚群对小鼠卵母细胞和颗粒细胞的作用机制。
我们鉴定出三种不同的功能亚型,包括间充质干细胞、多淋巴祖细胞和滋养层细胞。此外,我们还鉴定出了 LRP1 亚群,它能改善老年和 POF 小鼠的卵巢功能。我们阐明了 LRP1 亚群独特的分泌功能,能够分泌各种趋化因子、细胞因子和生长因子。此外,LRP1 在调节卵巢微环境中起着关键作用,包括组织修复和细胞外基质重塑。与它的功能一致,移植后卵母细胞和颗粒细胞的转录组表明,LRP1 亚群通过调节卵母细胞的细胞外基质、NAD 代谢和颗粒细胞中的线粒体功能来改善卵巢功能。
通过探索 UC-MSCs 的异质性,我们鉴定出 LRP1 亚群能够通过分泌各种因子和重塑细胞外基质来改善老年和 POF 小鼠的卵巢功能。这项研究为在 POF 的精确治疗中靶向探索人类 UC-MSCs 提供了新的见解。